Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of Shingrix in Renal Transplant Recipients

NCT04128189 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT04128189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04128189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of Shingrix in Renal Transplant Recipients
Lead sponsor
University of Colorado, Denver
Phase
Phase 3
Overall status
Recruiting
Start date
March 2, 2023
Completion date
June 30, 2029
Enrollment
132 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster (hz), kidney failure, kidney failure, chronic, kidney transplant recipient response to shingrix vaccine, kidney transplantation